Eukles Asset Management Illumina, Inc. Transaction History

Eukles Asset Management

$244 Million
Q3 2024

A detailed history of Eukles Asset Management transactions in Illumina, Inc. stock. As of the latest transaction made, Eukles Asset Management holds 6,179 shares of ILMN stock, worth $865,925. This represents 0.33% of its overall portfolio holdings.

Number of Shares

6,179

Previous 6,761 8.61%

Holding current value

$865,925

Previous $705,000 14.18%

% of portfolio

0.33%

Previous 0.31%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$105.28 - $135.9 $61,272 - $79,093	-582 Reduced 8.61%	6,179 $805,000
Q2 2024 Aug 01, 2024	BUY	$101.05 - $133.57 $4,749 - $6,277	47 Added 0.7%	6,761 $705,000
Q1 2024 May 13, 2024	BUY	$127.73 - $147.2 $123,387 - $142,195	966 Added 16.81%	6,714 $921,000
Q4 2023 Jan 31, 2024	SELL	$92.79 - $142.53 $18,001 - $27,650	-194 Reduced 3.26%	5,748 $800,000
Q3 2023 Oct 25, 2023	BUY	$128.91 - $192.44 $12,891 - $19,244	100 Added 1.71%	5,942 $815,000
Q2 2023 Aug 01, 2023	BUY	$183.43 - $232.67 $17,425 - $22,103	95 Added 1.65%	5,842 $1.1 Million
Q1 2023 Apr 28, 2023	BUY	$193.75 - $232.55 $9,881 - $11,860	51 Added 0.9%	5,747 $1.34 Million
Q4 2022 Jan 27, 2023	BUY	$187.24 - $242.74 $74,147 - $96,125	396 Added 7.47%	5,696 $1.15 Million
Q3 2022 Oct 28, 2022	BUY	$177.23 - $227.44 $73,195 - $93,932	413 Added 8.45%	5,300 $1.01 Million
Q2 2022 Jul 28, 2022	BUY	$181.58 - $368.0 $9,079 - $18,400	50 Added 1.03%	4,887 $901,000
Q1 2022 Apr 27, 2022	SELL	$303.87 - $423.8 $120,940 - $168,672	-398 Reduced 7.6%	4,837 $1.69 Million
Q4 2021 Feb 10, 2022	BUY	$347.28 - $421.83 $53,133 - $64,539	153 Added 3.01%	5,235 $1.99 Million
Q3 2021 Oct 28, 2021	BUY	$405.61 - $524.84 $77,065 - $99,719	190 Added 3.88%	5,082 $2.06 Million
Q2 2021 Jul 27, 2021	BUY	$372.84 - $481.5 $117,444 - $151,672	315 Added 6.88%	4,892 $2.32 Million
Q1 2021 Apr 27, 2021	BUY	$361.28 - $504.76 $39,740 - $55,523	110 Added 2.46%	4,577 $1.76 Million
Q4 2020 Jan 26, 2021	BUY	$292.7 - $370.96 $28,684 - $36,354	98 Added 2.24%	4,467 $1.65 Million
Q3 2020 Oct 29, 2020	BUY	$268.51 - $400.74 $9,934 - $14,827	37 Added 0.85%	4,369 $1.35 Million
Q2 2020 Jul 29, 2020	BUY	$256.46 - $373.01 $149,516 - $217,464	583 Added 15.55%	4,332 $1.6 Million
Q1 2020 Apr 22, 2020	SELL	$209.2 - $335.53 $125,520 - $201,317	-600 Reduced 13.8%	3,749 $1.02 Million
Q4 2019 Jan 24, 2020	SELL	$288.29 - $335.49 $14,414 - $16,774	-50 Reduced 1.14%	4,349 $1.44 Million
Q3 2019 Oct 29, 2019	SELL	$266.84 - $378.23 $1,067 - $1,512	-4 Reduced 0.09%	4,399 $1.34 Million
Q2 2019 Aug 01, 2019	BUY	$300.59 - $368.15 $1.32 Million - $1.62 Million	4,403 New	4,403 $1.62 Million

Others Institutions Holding ILMN

# of Institutions

899

Shares Held

137M

Call Options Held

1.22M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eukles Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Eukles Asset Management with notifications on news.

Account

Eukles Asset Management Illumina, Inc. Transaction History